Helena Pomares
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
ASSESSMENT OF THE IPSS-M IN CHRONIC MYELOMONOCYTIC LEUKEMIA.
Journal: Blood advances
Published: January 20, 2026
Assessing the impact of nutritional status at allogeneic stem cell transplantation on clinical outcomes.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: October 22, 2025
A scoring system to predict life-threatening thromboischemic events in patients with acute promyelocytic leukemia: the PETHEMA/PALG study.
Journal: Haematologica
Published: June 26, 2025
Prognostic value of measurable residual disease (MRD) for venetoclax in combination with hypomethylating agents in patients diagnosed with acute myeloid leukemia: validation of the ELN-2021 MRD recommendations.
Journal: Blood cancer journal
Published: February 11, 2025
Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study.
Journal: Experimental hematology & oncology
Published: December 26, 2024
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.
Journal: Blood cancer journal
Published: October 17, 2024
Arsenic trioxide-induced peripheral neuropathy: prospective clinical and neurophysiological evaluation in a cohort of patients with acute promyelocytic leukemia.
Journal: Leukemia & lymphoma
Published: August 14, 2024
Pericardial Disease in Patients with Cancer: Clinical Insights on Diagnosis and Treatment.
Journal: Cancers
Published: August 06, 2024
Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study.
Journal: Leukemia
Published: April 12, 2024
Chronic myelomonocytic leukemia with ring sideroblasts/SF3B1 mutation presents with low monocyte count and resembles myelodysplastic syndromes with-RS/SF3B1 mutation in terms of phenotype and prognosis.
Journal: Frontiers in oncology
Published: February 14, 2024
Last Updated: 09/26/2026